Hair loss with GLP-1 drugs is rare but real, studies find

Recent studies indicate that patients utilizing GLP-1 drugs for the treatment of obesity or diabetes experience a higher risk of hair loss compared to those using alternative diabetes medications. While the overall occurrence of this side effect is described as rare, the research confirms that the risk is real. These findings highlight a specific distinction in the safety profiles of GLP-1 drugs relative to other pharmacological options available for managing these chronic health conditions.